TVM closes latest life sciences fund on $201.6m

The VC firm’s seventh vehicle will invest in early-stage molecules

ByIsobel Markham

7 October 2014•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Managers North America